Gastroesophageal Reflux Disease Market - Forecast(2024 - 2030)

Report Code: HCR 26760 Report Format: PDF + Excel

Market Overview

The global Gastroesophageal Reflux Disease market is forecast to reach $7.81 billion by 2024, growing at a CAGR of 3.75% during the forecast period 2019-2024. This market is growing owing to the rise in the global alcohol consumption as well as the surge in geriatric population and the increasing prevalence of gastroesophageal reflux disease. Esophageal pH monitoring and esophageal impedance test are diagnostic tests that measures the amount and type of gastroesophageal reflux in the esophagus. These tests helps in identifying traces of esophageal stricture.


Key Takeaways

  • The North America Region is estimated to dominate the market owing to the rise in the prevalence of the disease as well as the geriatric population. Information on other major region’s Gastroesophageal Reflux Disease market size also mentioned in the final report.
  • The rise in the overall consumption of alcohol is considered as a major market driver as an increased alcohol consumption is linked with gastroesophageal reflux disease. Other major market drivers that have been considered are also mentioned in the final report.
  • Availability of a large number of OTC products are considered to have a negative effect on the overall market growth. This is owing to the fact that having these products will encourage self-treatment. Other major market limiters mentioned in the full, final report.

 

Drug Type - Segment Analysis

The major segment in drug type were held by antacids and are estimated to retain their top position over the forecast period. This is owing to the easy availability of antacid products in various forms such as in tablets, powders and syrups. The antacid products are also estimated to be the fastest growing segment as well and is estimated to hold a CAGR of 4.3%. Proton pump inhibitors such as Omeprazole provides long-lasting reduction of stomach acid production. It initiates lower esophageal sphincter to close which prevents stomach acid to travel back into the bowel.

Geography - Segment Analysis

The North America region is estimated to hold the largest Gastroesophageal Reflux Disease market share of 32%. This is owing to the rise in geriatric population who are prone to this disease as well as its increasing prevalence. However, the APAC region was found to have the fastest growth rate owing to the rise in geriatric population as well as the growing trend of self-treatment because of the availability of affordable, over the counter antacids.

Drivers – Gastroesophageal Reflux Disease Market

·         Rising Alcohol Consumption

Studies have shown that the consumption of alcohol will affect the prevalence of gastroesophageal reflux disease. The increasing consumption of alcohol will affect the overall prevalence of the disease and could contribute to the overall market growth.

·         Rising Geriatric population

The disease is more prevalent in elderly people and the growth of the elderly population has the potential to contribute greatly to the overall gastroesophageal reflux disease market.

Challenges – Gastroesophageal Reflux Disease Market

·         Availability of a large number of products

There is a large amount of products in the market that provides symptomatic treatment. This factor could be considered as a major challenge to the overall market as people may not know the difference in benefits between the products. There is also a lot of over the counter products for this disease as well.

Gastroesophageal Reflux Disease Industry Outlook

Product launches and acquisitions are the key strategies adopted by the players in the Gastroesophageal Reflux Disease industry. Gastroesophageal Reflux Disease top 10 companies include Teva Pharmaceutical Industries Ltd., AstraZaneca, Boston Scientific Corporation, Eisai Co., Ltd., Endogastric Solutions Inc., Endostim BV, Ironwood Pharmaceuticals Inc., Jeil Pharmaceutical Co., Ltd., Cheplapharm Arzneimittel GmbH and Pfizer Inc., among others.

Acquisitions/Product Launches

  • On October 2019, Cheplapharm Arzneimittel GmbH had announced that it acquired the commercial rights of the acid reflux treatment drug from AstraZeneca for $276 million. However, AstraZeneca will make and sell the drug wherever the rights are not included.
  • On November2017, EndoGastric Solution had introduced its new product for Transoral Incisionless Fundoplication procedures. This product is designed to reconstruct the gastroesophageal valve and to restore its function as a reflux barrier.

1. Gastroesophageal Reflux Disease Market - Overview
        1.1 Definitions and Scope
2. Gastroesophageal Reflux Disease Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Gastroesophageal Reflux Disease Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Gastroesophageal Reflux Disease Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Gastroesophageal Reflux Disease Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Gastroesophageal Reflux Disease Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Gastroesophageal Reflux Disease Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Gastroesophageal Reflux Disease Market - By Product Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Gastroesophageal Reflux Disease Market - By Drug (Market Size -$Million / $Billion)
        9.1 Antacid
        9.2 H2 Receptor Blocker
        9.3 Proton Pump Inhibitor
        9.4 Pro-Kinetic Agent
10. Gastroesophageal Reflux Disease - By Application Type (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. Gastroesophageal Reflux Disease- By Geography (Market Size -$Million / $Billion)
        11.1 Gastroesophageal Reflux Disease Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Gastroesophageal Reflux Disease- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Gastroesophageal Reflux Disease- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Gastroesophageal Reflux Disease - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Gastroesophageal Reflux Disease - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Gastroesophageal Reflux Disease Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Gastroesophageal Reflux Disease Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Gastroesophageal Reflux Disease Market - Key Company List by Country Premium
15. Gastroesophageal Reflux Disease Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Abbott
        15.3 Astrazeneca Plc
        15.4 Daewoong Pharmaceutical Co., Ltd
        15.5 Eisai Co , Ltd
        15.6 Glaxosmithkline Plc
        15.7 Ironwood Pharmaceuticals, Inc
        15.8 Johnson Johnson Services, Inc
        15.9 Novartis Ag
        15.10 Pfizer, Inc
        15.11 Raqualia Pharma, Inc
        15.12 Reckitt Benckiser Group Plc
        15.13 Sfj Pharmaceutical Group
        15.14 Sr Pharmaceutical Pvt. Ltd
        15.15 Takeda Pharmaceutical Co, Ltd
        15.16 Company 15
        15.17 Company 16 & More
*Financials would be provided on a best efforts basis for private companies
16. Gastroesophageal Reflux Disease Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Gastroesophageal Reflux Disease Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends